All AbMole products are for research use only, cannot be used for human consumption.
Tie2 kinase inhibitor is a potent, reversible, and ATP-binding site-targeting Tie2 inhibitor with an IC50 of 250 nM. Tie2 kinase inhibitor has a remarkable selectivity for Tie2 over p38 (IC50 = 50 μM) and a >10-fold selectivity over VEGFR2, VEGFR3 and PDGFR1β. Tie2 kinase inhibitor showed efficacy in an in vivo model of angiogenesis and a MOPC-315 plasmacytoma xenograft model. In addition to its activity as an inhibitor of Tie2 kinase, Tie2 kinase inhibitor also shows modest activity against a variety of cultured mammalian cells.
| Cell Experiment | |
|---|---|
| Cell lines | Human aortic endothelial cells (HAECs) |
| Preparation method | Treatment of HAECs with Ang1 and Tie2 inhibitors Before use, Ang1 was preincubated with anti-poly-histidine antibody (R&D Systems, Minneapolis, MN) to form dimers prior to the treatment of HAECs. Equal numbers of HAECs were grown to confluent monolayer and starved with serum-free EBM medium for 6 h. HAECs were pretreated with Tie2 inhibitors or the carrier DMSO (final concentration at 0.5%) for 1 h followed by the stimulation with dimerized Ang1 for 10 min at 37 C. The same amount of protein was loaded into each well of SDS–PAGE. |
| Concentrations | 0, 0.1, 0.3, 1µM |
| Incubation time | 1 h |
| Animal Experiment | |
|---|---|
| Animal models | Rat model of choroidal neovascularization (CNV) |
| Formulation | PBS |
| Dosages | 10 µg/µl |
| Administration | injection |
| Molecular Weight | 439.53 |
| Formula | C26H21N3O2S |
| CAS Number | 948557-43-5 |
| Solubility (25°C) | DMSO 17 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[1] Semones M, et al. Bioorg Med Chem Lett. Pyridinylimidazole inhibitors of Tie2 kinase.
[2] Zhou BN, et al. Org Lett. The first naturally occurring Tie2 kinase inhibitor.
| Related Products |
|---|
| 2-Deoxy-2-fluoro-D-glucose
2-Deoxy-2-fluoro-D-glucose is a radiolabeled glucose analog, which is commonly used in medical imaging techniques such as positron emission tomography (PET) scans. |
| 2-Bromo-4-chlorophenylacetic acid
2-Bromo-4-chlorophenylacetic acid is a biochemical reagent. |
| CPN-351 TFA
CPN-351 TFA is a selective pentapeptide antagonist of human NMUR1 with a pA2 of 7.35. CPN-351 TFA can be used for the research of inflammation. |
| 5-Phenyluracil
5-Phenyluracil is a pyrimidine derivative, a class of heterocyclic aromatic organic compounds crucial in biochemistry. It serves as a synthetic nucleoside analogue, meaning it mimics the structure of naturally occurring nucleosides like uridine. This structural similarity allows it to participate in biochemical reactions, often interfering with normal cellular processes, making it a valuable tool in studying nucleic acid metabolism and developing antiviral and anticancer agents. |
| 7-Deoxyloganin
7-Deoxyloganin is a biosynthetic precursor of Loganin. 7-Deoxyloganin undergoes hydroxylation catalyzed by 7-deoxyloganin 7-hydroxylase, a cytochrome P450-dependent monooxygenase, to produce Loganin. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
